Imran Alibhai serves as the Managing Director of the Houston office of DNAtrix. Prior to DNAtrix, he was an investment banker in Peter J. Solomon Company’s Healthcare Advisory Group, focused on M&A transactions in science based markets including biopharmaceuticals, medical devices/diagnostics and life science tools. Previously, he was the Senior Director of Alexandria Venture Investments, where he was responsible for the firm’s investments in emerging companies and funds in the healthcare sector. He also directed investments for PIPE’s and long/short positions in MPM Capital’s BioEquities hedge fund. Imran began his career in early stage venture capital at the Accelerator Corp., where he was involved in every facet of company / project formation and management. Imran holds a Ph.D. in Molecular Neuroscience from the University of Texas Southwestern Medical School and a B.S. in Biology from Duke University.
No upcoming events scheduled yet.
No past events posted.